Home/Filings/4/0001181431-14-005628
4//SEC Filing

Prothena Corp plc 4

Accession 0001181431-14-005628

$PRTACIK 0001559053operating

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 8:21 PM ET

Size

5.5 KB

Accession

0001181431-14-005628

Insider Transaction Report

Form 4
Period: 2014-02-04
Koller Martin
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2014-02-04+40,00040,000 total
    Exercise: $29.81Exp: 2024-02-04Ordinary Shares (40,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 4, 2015 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Issuer

Prothena Corp plc

CIK 0001559053

Entity typeoperating
IncorporatedIreland

Related Parties

1
  • filerCIK 0001559053

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 8:21 PM ET
Size
5.5 KB